Veracyte (VCYT)
57.88
0.00 (0.00%)
Upcoming Events
Latest Headlines
Piper Sandler Starts Veracyte, Inc (VCYT) at Overweight
July 15, 2026 4:09 AM - StreetInsider
Veracyte, Inc (VCYT) PT Raised to $60 at Canaccord
July 14, 2026 6:42 AM - StreetInsider
Veracyte to Release Second Quarter 2026 Financial Results on July 30, 2026
July 9, 2026 4:05 PM - BizWire
Veracyte, Inc (VCYT) PT Raised to $47 at Morgan Stanley
July 9, 2026 8:16 AM - StreetInsider
Veracyte, Inc (VCYT) PT Raised to $65 at Guggenheim
June 29, 2026 6:55 AM - StreetInsider
Form 4 VERACYTE, INC. For: Jun 18 Filed by: EASTHAM KARIN
June 22, 2026 4:31 PM - SEC Filing
Form 144 VERACYTE, INC. Filed by: EASTHAM KARIN
June 18, 2026 4:23 PM - SEC Filing
Form 4 VERACYTE, INC. For: Jun 11 Filed by: JONES EVAN/ FA
June 15, 2026 4:56 PM - SEC Filing
Form 4 VERACYTE, INC. For: Jun 11 Filed by: EASTHAM KARIN
June 15, 2026 4:56 PM - SEC Filing
Form 4 VERACYTE, INC. For: Jun 11 Filed by: Barr Eliav
June 15, 2026 4:56 PM - SEC Filing
Form 4 VERACYTE, INC. For: Jun 11 Filed by: Shafer David Brent
June 15, 2026 4:56 PM - SEC Filing
Form 4 VERACYTE, INC. For: Jun 11 Filed by: EPSTEIN ROBERT S
June 15, 2026 4:56 PM - SEC Filing
Form 4 VERACYTE, INC. For: Jun 11 Filed by: Holstein Jens
June 15, 2026 4:56 PM - SEC Filing
Form 4 VERACYTE, INC. For: Jun 11 Filed by: Miller Thomas F.
June 15, 2026 4:56 PM - SEC Filing
Form 4 VERACYTE, INC. For: Jun 11 Filed by: Bhanji Muna
June 15, 2026 4:56 PM - SEC Filing
Form 8-K VERACYTE, INC. For: Jun 10
June 11, 2026 4:33 PM - SEC Filing
Form S-8 VERACYTE, INC.
June 10, 2026 4:17 PM - SEC Filing
Form SCHEDULE 13G/A VERACYTE, INC. Filed by: FMR LLC
June 5, 2026 10:13 AM - SEC Filing
Form 4 VERACYTE, INC. For: Jun 02 Filed by: McGuire Annie
June 4, 2026 9:39 PM - SEC Filing
Form 4 VERACYTE, INC. For: Jun 02 Filed by: Wygant Jonathan
June 4, 2026 9:39 PM - SEC Filing
Form 4 VERACYTE, INC. For: Jun 02 Filed by: Chambers Rebecca
June 4, 2026 9:39 PM - SEC Filing
Form 4 VERACYTE, INC. For: Jun 02 Filed by: Stapley Marc
June 4, 2026 9:39 PM - SEC Filing
Form 4 VERACYTE, INC. For: Jun 02 Filed by: Febbo Phillip G.
June 4, 2026 9:39 PM - SEC Filing
Form 4 VERACYTE, INC. For: Jun 02 Filed by: Leite John
June 4, 2026 9:39 PM - SEC Filing
Form 144 VERACYTE, INC. Filed by: McGuire Annie
June 4, 2026 4:33 PM - SEC Filing
Form 144 VERACYTE, INC. Filed by: Leite John
June 4, 2026 4:32 PM - SEC Filing
Form 144 VERACYTE, INC. Filed by: Stapley Marc
June 4, 2026 4:32 PM - SEC Filing
Form 144 VERACYTE, INC. Filed by: Chambers Rebecca
June 4, 2026 4:31 PM - SEC Filing
Canaccord Reiterates Hold Rating on Veracyte, Inc (VCYT)
June 2, 2026 6:53 AM - StreetInsider
Wolfe Research Assumes Veracyte, Inc (VCYT) at Outperform
June 1, 2026 4:23 PM - StreetInsider
Veracyte, Inc (VCYT) PT Raised to $57 at Needham
June 1, 2026 11:06 AM - StreetInsider
Veracyte launches Prosigna breast cancer test in US market
June 1, 2026 7:30 AM - StreetInsider
Veracyte Announces Commercial Launch of the Prosigna Breast Test in the U.S.
June 1, 2026 7:30 AM - BizWire
ENZAMET Trial Shows Veracyte's Decipher Prostate Test Identifies Which Patients Benefit from Adding Chemotherapy in Metastatic Prostate Cancer
May 30, 2026 8:00 AM - BizWire
Landmark OPTIMA Trial Delivers Practice-Changing Evidence that Veracyte’s Prosigna Test Identifies Patients with High-Risk Breast Cancer Who Can Safely Avoid Chemotherapy
May 29, 2026 3:15 PM - BizWire
Form 4 VERACYTE, INC. For: May 22 Filed by: Wygant Jonathan
May 27, 2026 4:19 PM - SEC Filing
Form 4 VERACYTE, INC. For: May 20 Filed by: EPSTEIN ROBERT S
May 22, 2026 4:39 PM - SEC Filing
Veracyte to Host Investor Call on June 1, 2026 to Discuss ASCO Findings
May 22, 2026 8:00 AM - BizWire
OPTIMA Trial Results to Be Presented at ASCO Provide New Evidence Supporting Prosigna-Guided Chemotherapy Decisions in Breast Cancer
May 21, 2026 6:00 PM - BizWire
Form 144 VERACYTE, INC. Filed by: EPSTEIN ROBERT S
May 20, 2026 4:39 PM - SEC Filing
Veracyte to Participate in Upcoming Investor Conferences
May 19, 2026 4:05 PM - BizWire
Veracyte receives Medicare coverage for bladder cancer monitoring test
May 15, 2026 9:00 AM - StreetInsider
Veracyte Secures Medicare Coverage for TrueMRD Monitoring Test in Muscle-Invasive Bladder Cancer
May 15, 2026 9:00 AM - BizWire
A Toronto AI-Cardiac Diagnostics Company Just Cleared Three of the Hardest Validation Bars in Medtech
May 13, 2026 9:00 AM - Globe NewsWire
Form SCHEDULE 13G/A VERACYTE, INC. Filed by: Artisan Partners Limited Partnership
May 13, 2026 7:00 AM - SEC Filing
Form SCHEDULE 13G VERACYTE, INC. Filed by: STATE STREET CORP
May 12, 2026 12:19 PM - SEC Filing
Form 4 VERACYTE, INC. For: May 06 Filed by: McGuire Annie
May 8, 2026 4:25 PM - SEC Filing
Form 144 VERACYTE, INC. Filed by: McGuire Annie
May 6, 2026 4:26 PM - SEC Filing
Form SCHEDULE 13G/A VERACYTE, INC. Filed by: FMR LLC
May 6, 2026 11:41 AM - SEC Filing
Veracyte, Inc (VCYT) PT Raised to $52 at UBS
May 6, 2026 9:29 AM - StreetInsider
Form 10-Q VERACYTE, INC. For: Mar 31
May 6, 2026 8:08 AM - SEC Filing
Veracyte, Inc (VCYT) PT Raised to $42 at Canaccord
May 6, 2026 6:52 AM - StreetInsider
Veracyte (VCYT) Tops Q1 EPS by 19c, provides guidance
May 5, 2026 4:15 PM - StreetInsider
Form 8-K VERACYTE, INC. For: May 05
May 5, 2026 4:09 PM - SEC Filing
Veracyte Announces First Quarter 2026 Financial Results
May 5, 2026 4:05 PM - BizWire
Form SCHEDULE 13G VERACYTE, INC. Filed by: VANGUARD CAPITAL MANAGEMENT LLC
April 30, 2026 2:35 PM - SEC Filing
Form SCHEDULE 13G VERACYTE, INC. Filed by: VANGUARD PORTFOLIO MANAGEMENT LLC
April 29, 2026 3:55 PM - SEC Filing
Veracyte Announces New Data at AUA 2026 Highlighting the Power of the Decipher Portfolio to Advance Personalized Care in Urologic Cancers
April 28, 2026 9:00 AM - BizWire
Full Article List
